Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers.
Journal: Signal transduction and targeted therapy
Published: March 16, 2025
Correction: Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
Journal: Cancer research
Published: May 02, 2024
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma.
Journal: British journal of cancer
Published: September 23, 2023
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Journal: Journal of ovarian research
Published: August 24, 2023
Structural basis for antibody recognition of the proximal MUC16 ectodomain.
Journal: Journal of ovarian research
Published: August 09, 2023
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
Journal: JAMA oncology
Published: July 28, 2022
Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy.
Journal: American journal of clinical oncology
Published: November 24, 2021
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
Journal: Cancer research
Published: July 09, 2021
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents.
Journal: Molecular cancer therapeutics
Published: June 30, 2021
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: June 07, 2021
Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.
Journal: Frontiers in immunology
Published: February 02, 2021
Addressing cervical cancer screening disparities through advances in artificial intelligence and nanotechnologies for cellular profiling.
Journal: Biophysics reviews
Published: January 06, 2021
Last Updated: 09/26/2026